Phase 1 dose-escalation study of BI 836909, an anti-BCMA bi-specific T-cell engager, in relapsed and/or refractory multiple myeloma (RRMM)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 34; no. 15_suppl; p. TPS8067
Main Authors Topp, Max S., Attal, Michel, Langer, Christian, Moreau, Philippe, Facon, Thierry, Düll, Johannes, Hebraud, Benjamin, Gomez-Roca, Carlos, Munzert, Gerd Michael, Gracien, Edith, Zugmaier, Gerhard, Einsele, Hermann
Format Journal Article
LanguageEnglish
Published 20.05.2016
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2016.34.15_suppl.TPS8067